We analyzed survival and causes of death among 163 patients with primary hemochromatosis diagnosed between 1959 and 1983. The mean follow-up period was 10.5 +/- 5.6 years (+/- S.D.). Cumulative survival was 92 per cent at 5 years, 76 per cent at 10 years, 59 per cent at 15 years, and 49 per cent at 20 years. Life expectancy was reduced in patients with cirrhosis of the liver as compared with those without cirrhosis (P less than or equal to 0.05), in patients with diabetes mellitus as compared with those without diabetes (P less than or equal to 0.002), and in patients who could not be depleted of iron during the first 18 months of venesection therapy as compared with those who could be depleted (P less than or equal to 0.001). Prognosis was not influenced by sex (P less than or equal to 0.5). Patients without cirrhosis had a life expectancy that was not different from that expected in an age- and sex-matched normal population. Analysis of the causes of death in 53 patients, as compared with the normal population, showed that liver cancer was 219 times more frequent among the patients (16 patients), cardiomyopathy was 306 times more frequent (3 patients), liver cirrhosis was 13 times more frequent (10 patients), and diabetes mellitus was 7 times more frequent (3 patients). Death rates for other causes, including extrahepatic carcinomas (seven patients), were not different from the rates expected. We conclude that patients with hemochromatosis diagnosed in the precirrhotic stage and treated by venesection have a normal life expectancy, whereas cirrhotic patients have a shortened life expectancy and a high risk of liver cancer even when complete iron depletion has been achieved.
This article has been cited by other articles:
Chandarana, H., Lim, R. P., Jensen, J. H., Hajdu, C. H., Losada, M., Babb, J. S., Huffman, S., Taouli, B.
(2009). Hepatic Iron Deposition in Patients With Liver Disease: Preliminary Experience With Breath-Hold Multiecho T2*-Weighted Sequence. Am. J. Roentgenol.
193: 1261-1267
[Abstract][Full Text]
Edgren, G., Nyren, O., Melbye, M.
(2008). Cancer as a Ferrotoxic Disease: Are We Getting Hard Stainless Evidence?. JNCI J Natl Cancer Inst
100: 976-977
[Full Text]
Yamaguchi, K., Mandai, M., Toyokuni, S., Hamanishi, J., Higuchi, T., Takakura, K., Fujii, S.
(2008). Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress. Clin. Cancer Res.
14: 32-40
[Abstract][Full Text]
Kingston, J., Bowen, D., Sweeney, M., Lawless, S., Jackson, H., Worwood, M.
(2007). Heteroduplex analysis for the three common HFE variants: methodology, reliablity and analysis of over 5000 requests for testing. J. Clin. Pathol.
60: 1244-1248
[Abstract][Full Text]
Alizadeh, B Z, Njajou, O T, Hazes, J M W, Hofman, A, Slagboom, P E, Pols, H A P, van Duijn, C M
(2007). The H63D variant in the HFE gene predisposes to arthralgia, chondrocalcinosis and osteoarthritis. Ann Rheum Dis
66: 1436-1442
[Abstract][Full Text]
Hutchinson, C., Geissler, C. A, Powell, J. J, Bomford, A.
(2007). Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut
56: 1291-1295
[Abstract][Full Text]
Siegmund, S. V., Qian, T., de Minicis, S., Harvey-White, J., Kunos, G., Vinod, K. Y., Hungund, B., Schwabe, R. F.
(2007). The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J.
21: 2798-2806
[Abstract][Full Text]
Lehmann, U., Wingen, L. U., Brakensiek, K., Wedemeyer, H., Becker, T., Heim, A., Metzig, K., Hasemeier, B., Kreipe, H., Flemming, P.
(2007). Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis. Hum Mol Genet
16: 1335-1342
[Abstract][Full Text]
Petrak, J., Myslivcova, D., Man, P., Cmejla, R., Cmejlova, J., Vyoral, D., Elleder, M., Vulpe, C. D.
(2007). Proteomic analysis of hepatic iron overload in mice suggests dysregulation of urea cycle, impairment of fatty acid oxidation, and changes in the methylation cycle. Am. J. Physiol. Gastrointest. Liver Physiol.
292: G1490-G1498
[Abstract][Full Text]
Corthals, S. M., Kamendulis, L. M., Klaunig, J. E.
(2006). Mechanisms of 2-Butoxyethanol-Induced Hemangiosarcomas. Toxicol Sci
92: 378-386
[Abstract][Full Text]
Whitlock, E. P., Garlitz, B. A., Harris, E. L., Beil, T. L., Smith, P. R.
(2006). Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.. ANN INTERN MED
145: 209-223
[Abstract][Full Text]
Vantyghem, M.-C., Fajardy, I., Dhondt, F., Girardot, C., D'Herbomez, M., Danze, P.-M., Rousseaux, J., Wemeau, J.-L.
(2006). Phenotype and HFE genotype in a population with abnormal iron markers recruited from an Endocrinology Department.. Eur J Endocrinol
154: 835-841
[Abstract][Full Text]
Schmitt, B., Golub, R. M., Green, R.
(2005). Screening Primary Care Patients for Hereditary Hemochromatosis with Transferrin Saturation and Serum Ferritin Level: Systematic Review for the American College of Physicians. ANN INTERN MED
143: 522-536
[Abstract][Full Text]
Chan, A. T., Ma, J., Tranah, G. J., Giovannucci, E. L., Rifai, N., Hunter, D. J., Fuchs, C. S.
(2005). Hemochromatosis Gene Mutations, Body Iron Stores, Dietary Iron, and Risk of Colorectal Adenoma in Women. JNCI J Natl Cancer Inst
97: 917-926
[Abstract][Full Text]
Silber, S. J., Grotjan, H. E.
(2004). Microscopic Vasectomy Reversal 30 Years Later: A Summary of 4010 Cases by the Same Surgeon. J Androl
25: 845-859
[Full Text]
Saffroy, R., Pham, P., Chiappini, F., Gross-Goupil, M., Castera, L., Azoulay, D., Barrier, A., Samuel, D., Debuire, B., Lemoine, A.
(2004). The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. Carcinogenesis
25: 1443-1448
[Abstract][Full Text]
Pietrangelo, A.
(2004). Hereditary Hemochromatosis -- A New Look at an Old Disease. NEJM
350: 2383-2397
[Full Text]
Mainous, A. G. III, Gill, J. M., Carek, P. J.
(2004). Elevated Serum Transferrin Saturation and Mortality. Ann Fam Med
2: 133-138
[Abstract][Full Text]
Beutler, E.
(2004). Natural History of Hemochromatosis. Mayo Clin Proc.
79: 305-306
Choudhury, S., Zhang, R., Frenkel, K., Kawamori, T., Chung, F.-L., Roy, R.
(2003). Evidence of Alterations in Base Excision Repair of Oxidative DNA Damage during Spontaneous Hepatocarcinogenesis in Long Evans Cinnamon Rats. Cancer Res.
63: 7704-7707
[Abstract][Full Text]
Dubois, S., Kowdley, K. V.
(2003). The Importance of Screening for Hemochromatosis. Arch Intern Med
163: 2424-2426
[Full Text]
Walshe, J.M., Waldenstrom, E., Sams, V., Nordlinder, H., Westermark, K.
(2003). Abdominal malignancies in patients with Wilson's disease. QJM
96: 657-662
[Abstract][Full Text]
Morrison, E. D., Brandhagen, D. J., Phatak, P. D., Barton, J. C., Krawitt, E. L., El-Serag, H. B., Gordon, S. C., Galan, M. V., Tung, B. Y., Ioannou, G. N., Kowdley, K. V.
(2003). Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis. ANN INTERN MED
138: 627-633
[Abstract][Full Text]
Bilello, J. P., Cable, E. E., Isom, H. C.
(2003). Expression of E-Cadherin and Other Paracellular Junction Genes Is Decreased in Iron-Loaded Hepatocytes. Am. J. Pathol.
162: 1323-1338
[Abstract][Full Text]
Shaheen, N. J., Silverman, L. M., Keku, T., Lawrence, L. B., Rohlfs, E. M., Martin, C. F., Galanko, J., Sandler, R. S.
(2003). Association Between Hemochromatosis (HFE) Gene Mutation Carrier Status and the Risk of Colon Cancer. JNCI J Natl Cancer Inst
95: 154-159
[Abstract][Full Text]
Beutler, E., Hoffbrand, A. V., Cook, J. D.
(2003). Iron Deficiency and Overload. ASH Education Book
2003: 40-61
[Abstract][Full Text]
Mainous III, A. G., Gill, J. M., Pearson, W. S.
(2002). Should We Screen for Hemochromatosis?: An Examination of Evidence of Downstream Effects on Morbidity and Mortality. Arch Intern Med
162: 1769-1774
[Abstract][Full Text]
Park, J., Kamendulis, L. M., Klaunig, J. E.
(2002). Mechanisms of 2-Butoxyethanol Carcinogenicity: Studies on Syrian Hamster Embryo (SHE) Cell Transformation. Toxicol Sci
68: 43-50
[Abstract][Full Text]
Waalen, J., Felitti, V., Gelbart, T., Ho, N. J., Beutler, E.
(2002). Prevalence of Hemochromatosis-Related Symptoms Among Individuals With Mutations in the HFE Gene. Mayo Clin Proc.
77: 522-530
[Abstract]
Stewart, S.F., Day, C.P.
(2001). Liver disorder and the HFE locus. QJM
94: 453-456
[Full Text]
Hanson, E. H., Imperatore, G., Burke, W.
(2001). HFE Gene and Hereditary Hemochromatosis: A HuGE Review. Am J Epidemiol
154: 193-206
[Abstract][Full Text]
Turner, M. S., Penning, S., Sharp, A., Hyland, V. J., Harris, R., Morris, C. P., van Daal, A.
(2001). Solid-Phase Amplification for Detection of C282Y and H63D Hemochromatosis (HFE) Gene Mutations. Clin. Chem.
47: 1384-1389
[Abstract][Full Text]
Moczulski, D. K., Grzeszczak, W., Gawlik, B.
(2001). Role of Hemochromatosis C282Y and H63D Mutations in HFE Gene in Development of Type 2 Diabetes and Diabetic Nephropathy. Diabetes Care
24: 1187-1191
[Abstract][Full Text]
Krinsky, G. A., Lee, V. S., Nguyen, M. T., Rofsky, N. M., Theise, N. D., Morgan, G. R., Teperman, L. W., Weinreb, J. C.
(2001). Siderotic Nodules in the Cirrhotic Liver at MR Imaging with Explant Correlation: No Increased Frequency of Dysplastic Nodules and Hepatocellular Carcinoma. Radiology
218: 47-53
[Abstract][Full Text]
Griffiths, W., Cox, T.
(2000). Haemochromatosis: novel gene discovery and the molecular pathophysiology of iron metabolism. Hum Mol Genet
9: 2377-2382
[Abstract][Full Text]
Mori, N., Hirayama, K.
(2000). Long-Term Consumption of a Methionine-Supplemented Diet Increases Iron and Lipid Peroxide Levels in Rat Liver. J. Nutr.
130: 2349-2355
[Abstract][Full Text]
Yu, M.-W., Chang, H.-C., Liaw, Y.-F., Lin, S.-M., Lee, S.-D., Liu, C.-J., Chen, P.-J., Hsiao, T.-J., Lee, P.-H., Chen, C.-J.
(2000). Familial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives. JNCI J Natl Cancer Inst
92: 1159-1164
[Abstract][Full Text]
BENYON, R C, IREDALE, J P
(2000). Is liver fibrosis reversible?. Gut
46: 443-446
[Full Text]
Chisari, F. V.
(2000). Viruses, Immunity, and Cancer: Lessons from Hepatitis B. Am. J. Pathol.
156: 1117-1132
[Full Text]
El-Serag, H. B., Inadomi, J. M., Kowdley, K. V.
(2000). Screening for Hereditary Hemochromatosis in Siblings and Children of Affected Patients: A Cost-Effectiveness Analysis. ANN INTERN MED
132: 261-269
[Abstract][Full Text]
Nowicki, M. J., Bacon, B. R.
(2000). Hereditary Hemochromatosis in Siblings: Diagnosis by Genotyping. Pediatrics
105: 426-428
[Full Text]
Tuomainen, T.-P., Kontula, K., Nyyssonen, K., Lakka, T. A., Helio, T., Salonen, J. T.
(1999). Increased Risk of Acute Myocardial Infarction in Carriers of the Hemochromatosis Gene Cys282Tyr Mutation : A Prospective Cohort Study in Men in Eastern Finland. Circulation
100: 1274-1279
[Abstract][Full Text]
Pascoe, A, Kerlin, P, Steadman, C, Clouston, A, Jones, D, Powell, L, Jazwinska, E, Lynch, S, Strong, R
(1999). Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation. Gut
45: 301-305
[Abstract][Full Text]
Bonkovsky, H. L., Rubin, R. B., Cable, E. E., Davidoff, A., Pels Rijcken, T. H., Stark, D. D.
(1999). Hepatic Iron Concentration: Noninvasive Estimation by Means of MR Imaging Techniques. Radiology
212: 227-234
[Abstract][Full Text]
Ito, K., Mitchell, D. G., Gabata, T., Hann, H.-W. L., Kim, P. N., Fujita, T., Awaya, H., Honjo, K., Matsunaga, N.
(1999). Hepatocellular Carcinoma: Association with Increased Iron Deposition in the Cirrhotic Liver at MR Imaging. Radiology
212: 235-240
[Abstract][Full Text]
Bacon, B. R., Olynyk, J. K., Brunt, E. M., Britton, R. S., Wolff, R. K.
(1999). HFE Genotype in Patients with Hemochromatosis and Other Liver Diseases. ANN INTERN MED
130: 953-962
[Abstract][Full Text]
Davis, C. D., Feng, Y.
(1999). Dietary Copper, Manganese and Iron Affect the Formation of Aberrant Crypts in Colon of Rats Administered 3,2'-Dimethyl-4-Aminobiphenyl. J. Nutr.
129: 1060-1067
[Abstract][Full Text]
Lowes, K. N., Brennan, B. A., Yeoh, G. C., Olynyk, J. K.
(1999). Oval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity. Am. J. Pathol.
154: 537-541
[Abstract][Full Text]
Burt, M J, George, P M, Upton, J D, Collett, J A, Frampton, C M A, Chapman, T M, Walmsley, T A, Chapman, B A
(1998). The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut
43: 830-836
[Abstract][Full Text]
Barton, J. C., McDonnell, S. M., Adams, P. C., Brissot, P., Powell, L. W., Edwards, C. Q., Cook, J. D., Kowdley, K. V., The Hemochromatosis Management Working Group*,
(1998). Management of Hemochromatosis. ANN INTERN MED
129: 932-939
[Abstract][Full Text]
Yang, Q., McDonnell, S. M., Khoury, M. J., Cono, J., Parrish, R. G.
(1998). Hemochromatosis-Associated Mortality in the United States from 1979 to 1992: An Analysis of Multiple-Cause Mortality Data. ANN INTERN MED
129: 946-953
[Abstract][Full Text]
Cogswell, M. E., McDonnell, S. M., Khoury, M. J., Franks, A. L., Burke, W., Brittenham, G.
(1998). Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening. ANN INTERN MED
129: 971-979
[Abstract][Full Text]
Wetterhall, S. F., Cogswell, M. E., Kowdley, K. V.
(1998). Public Health Surveillance for Hereditary Hemochromatosis. ANN INTERN MED
129: 980-986
[Abstract][Full Text]
Kowdley, K. V., Kaplan, M. M.
(1998). Iron-Chelation Therapy with Oral Deferiprone -- Toxicity or Lack of Efficacy?. NEJM
339: 468-469
[Full Text]
Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P., Chisari, F. V.
(1998). Immune Pathogenesis of Hepatocellular Carcinoma. JEM
188: 341-350
[Abstract][Full Text]
Cragg, L., Hebbel, R. P., Miller, W., Solovey, A., Selby, S., Enright, H.
(1998). The Iron Chelator L1 Potentiates Oxidative DNA Damage in Iron-Loaded Liver Cells. Blood
92: 632-638
[Abstract][Full Text]
George, D K, Ramm, G A, Powell, L W, Fletcher, L M, Walker, N I, Cowley, L L, Crawford, D H G
(1998). Evidence for altered hepatic matrix degradation in genetic haemochromatosis. Gut
42: 715-720
[Abstract][Full Text]
GOLDWURM, S, POWELL, L W
(1997). Haemochromatosis after the discovery of HFE ("HLA-H"). Gut
41: 855-856
[Full Text]
Cullen, L. M., Summerville, L., Glassick, T. V., Crawford, D. H.G., Powell, L. W., Jazwinska, E. C.
(1997). Neonatal Screening for the Hemochromatosis Defect. Blood
90: 4236-4236
[Full Text]
Whittaker, P., Dunkel, V. C., Bucci, T. J., Kusewitt, D. F, Thurman, J. D., Warbritton, A., Wolff, G. L.
(1997). Genome-Linked Toxic Responses to Dietary Iron Overload. Toxicol Pathol
25: 556-564
[Abstract]
Arnold, J D, Mumford, A D, Lindsay, J O, Hegde, U, Hagan, M, Hawkins, J R
(1997). Hyperferritinaemia in the absence of iron overload. Gut
41: 408-410
[Abstract][Full Text]
Olivieri, N. F., Brittenham, G. M.
(1997). Iron-Chelating Therapy and the Treatment of Thalassemia. Blood
89: 739-761
[Full Text]
McLaren, C. E
(1996). Mixture models in haematology: a series of case studies. Stat Methods Med Res
5: 129-153
[Abstract]
Phatak, P. D., Guzman, G., Woll, J. E., Robeson, A., Phelps, C. E.
(1994). Cost-effectiveness of Screening for Hereditary Hemochromatosis. Arch Intern Med
154: 769-776
[Abstract]
Billings, P. R., Barash, C., Geller, L. N., Alper, J. S., Maguire, G. A., Edwards, C. Q., Kushner, J. P.
(1993). Screening for Hemochromatosis. NEJM
329: 2037-2038
[Full Text]
Friedman, S. L.
(1993). The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies. NEJM
328: 1828-1835
[Full Text]
Rouault, T. A.
(1993). Hereditary Hemochromatosis. JAMA
269: 3152-3154
[Abstract]
Edwards, C. Q., Kushner, J. P.
(1993). Screening for Hemochromatosis. NEJM
328: 1616-1620
[Full Text]
Stremmel, W., Meyerrose, K.-W., Niederau, C., Hefter, H., Kreuzpaintner, G., Strohmeyer, G.
(1991). Wilson Disease: Clinical Presentation, Treatment, and Survival. ANN INTERN MED
115: 720-726
[Abstract]
Crosby, W. H.
(1986). Hemochromatosis: Treatment to Alleviate Injury. Arch Intern Med
146: 1910-1911
[Abstract]
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., Loreal, O.
(2001). A New Mouse Liver-specific Gene, Encoding a Protein Homologous to Human Antimicrobial Peptide Hepcidin, Is Overexpressed during Iron Overload. J. Biol. Chem.
276: 7811-7819
[Abstract][Full Text]
Hussain, S. P., Raja, K., Amstad, P. A., Sawyer, M., Trudel, L. J., Wogan, G. N., Hofseth, L. J., Shields, P. G., Billiar, T. R., Trautwein, C., Hohler, T., Galle, P. R., Phillips, D. H., Markin, R., Marrogi, A. J., Harris, C. C.
(2000). Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: Oxyradical overload diseases. Proc. Natl. Acad. Sci. USA
97: 12770-12775
[Abstract][Full Text]
Previous
